MicroRNA‐18 and microRNA‐19 regulate CTGF and TSP‐1 expression in age‐related heart failure

Abstract

Summary To understand the process of cardiac aging, it is of crucial importance to gain insight into the age‐related changes in gene expression in the senescent failing heart. Age‐related cardiac remodeling is known to be accompanied by changes in extracellular matrix (ECM) gene and protein levels. Small noncoding microRNAs regulate gene expression in cardiac development and disease and have been implicated in the aging process and in the regulation of ECM proteins. However, their role in age‐related cardiac remodeling and heart failure is unknown. In this study, we investigated the aging‐associated microRNA cluster 17–92, which targets the ECM proteins connective tissue growth factor (CTGF) and thrombospondin‐1 (TSP‐1). We employed aged mice with a failure‐resistant (C57Bl6) and failure‐prone (C57Bl6 × 129Sv) genetic background and extrapolated our findings to human age‐associated heart failure. In aging‐associated heart failure, we linked an aging‐induced increase in the ECM proteins CTGF and TSP‐1 to a decreased expression of their targeting microRNAs 18a, 19a, and 19b, all members of the miR‐17–92 cluster. Failure‐resistant mice showed an opposite expression pattern for both the ECM proteins and the microRNAs. We showed that these expression changes are specific for cardiomyocytes and are absent in cardiac fibroblasts. In cardiomyocytes, modulation of miR‐18/19 changes the levels of ECM proteins CTGF and TSP‐1 and collagens type 1 and 3. Together, our data support a role for cardiomyocyte‐derived miR‐18/19 during cardiac aging, in the fine‐tuning of cardiac ECM protein levels. During aging, decreased miR‐18/19 and increased CTGF and TSP‐1 levels identify the failure‐prone heart.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 49

1. 1.

   Barasch E, Gottdiener JS, Aurigemma G, Kitzman DW, Han J, Kop WJ, Tracy RP. Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study. Circ. Heart Fail. 2009;2:303-310.

   Not in our library10.1161/circheartfailure.108.828343

2. 2.

   Belmadani S, Bernal J, Wei CC, Pallero MA, Dell'italia L, Murphy-Ullrich JE, Berecek KH. A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. Am. J. Pathol. 2007;171:777-789.

   Not in our library10.2353/ajpath.2007.070056

3. 3.

   Bodyak N, Kang PM, Hiromura M, Sulijoadikusumo I, Horikoshi N, Khrapko K, Usheva A. Gene expression profiling of the aging mouse cardiac myocytes. Nucleic Acids Res. 2002;30:3788-3794.

   Not in our library10.1093/nar/gkf497

4. 4.

   Boehm M, Slack F. A developmental timing microRNA and its target regulate life span in C. elegans. Science. 2005;310:1954-1957.

   Not in our library10.1126/science.1115596

5. 5.

   Boyle AJ, Shih H, Hwang J, Ye J, Lee B, Zhang Y, Kwon D, Jun K, Zheng D, Sievers R, Angeli F, Yeghiazarians Y, Lee R. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp. Gerontol. 2011.

   Not in our library10.1016/j.exger.2011.02.010

6. 6.

   Bradshaw AD, Baicu CF, Rentz TJ, Van LaerAO, Bonnema DD, Zile MR. Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing. Am. J. Physiol. Heart Circ. Physiol. 2010;298:H614-H622.

   Not in our library10.1152/ajpheart.00474.2009

7. 7.

   Brosh R, Shalgi R, Liran A, Landan G, Korotayev K, Nguyen GH, Enerly E, Johnsen H, Buganim Y, Solomon H, Goldstein I, Madar S, Goldfinger N, Borresen-Dale AL, Ginsberg D, Harris CC, Pilpel Y, Oren M, Rotter V. p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol. Syst. Biol. 2008;4:229.

   Not in our library10.1038/msb.2008.65

8. 8.

   Burgess ML, McCrea JC, Hedrick HL. Age-associated changes in cardiac matrix and integrins. Mech. Ageing Dev. 2001;122:1739-1756.

   Not in our library10.1016/s0047-6374(01)00296-2

9. 9.

   Campisi J. Cancer and ageing: rival demons? Nat. Rev. Cancer. 2003;3:339-349.

   Not in our library10.1038/nrc1073

10. 10.

    Capasso JM, Palackal T, Olivetti G, Anversa P. Severe myocardial dysfunction induced by ventricular remodeling in aging rat hearts. Am. J. Physiol. 1990;259:H1086-H1096.

    Not in our library10.1152/ajpheart.1990.259.4.h1086

11. 11.

    Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH. CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J. Mol. Cell. Cardiol. 2000;32:1805-1819.

    Not in our library10.1006/jmcc.2000.1215

12. 12.

    Chen LH, Chiou GY, Chen YW, Li HY, Chiou SH. microRNA and aging: a novel modulator in regulating the aging network. Ageing Res. Rev. 2010;9(Suppl 1):S59-S66.

    Not in our library10.1016/j.arr.2010.08.002

13. 13.

    da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, el Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, van der Nagel R, van Kuik J, de Weger R, de Bruin A, Condorelli G, Arbones ML, Eschenhagen T, De Windt LJ. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat. Cell Biol. 2010;12:1220-1227.

    Not in our library10.1038/ncb2126

14. 14.

    De Windt LJ, Willemsen PH, Popping S, Van der Vusse GJ, Reneman RS, Van Bilsen M. Cloning and cellular distribution of a group II phospholipase A2 expressed in the heart. J. Mol. Cell. Cardiol. 1997;29:2095-2106.

    Not in our library10.1006/jmcc.1997.0444

15. 15.

    Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 2006;38:1060-1065.

    Not in our library10.1038/ng1855

16. 16.

    Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, Maessen JG, Heymans S, Pinto YM, Creemers EE. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ. Res. 2009;104:170-178.

    Not in our library10.1161/circresaha.108.182535

17. 17.

    Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J, Entman ML. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation. 2005;111:2935-2942.

    Not in our library10.1161/circulationaha.104.510354

18. 18.

    Grillari J, Grillari-Voglauer R. Novel modulators of senescence, aging, and longevity: small non-coding RNAs enter the stage. Exp. Gerontol. 2010;45:302-311.

    Not in our library10.1016/j.exger.2010.01.007

19. 19.

    van Haaften G, Agami R. Tumorigenicity of the miR-17-92 cluster distilled. Genes Dev. 2010;24:1-4.

    Not in our library10.1101/gad.1887110

20. 20.
    miR‐17, miR‐19b, miR‐20a, and miR‐106a are down‐regulated in human aging · 2010

    No notice
21. 21.

    He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM. A microRNA polycistron as a potential human oncogene. Nature. 2005;435:828-833.

    Not in our library10.1038/nature03552

22. 22.

    Hong L, Lai M, Chen M, Xie C, Liao R, Kang YJ, Xiao C, Hu WY, Han J, Sun P. The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res. 2010;70:8547-8557.

    Not in our library10.1158/0008-5472.can-10-1938

23. 23.

    Kemi M, Keenan KP, McCoy C, Hoe CM, Soper KA, Ballam GC, van Zwieten MJ. The relative protective effects of moderate dietary restriction versus dietary modification on spontaneous cardiomyopathy in male Sprague-Dawley rats. Toxicol. Pathol. 2000;28:285-296.

    Not in our library10.1177/019262330002800208

24. 24.

    Koitabashi N, Arai M, Kogure S, Niwano K, Watanabe A, Aoki Y, Maeno T, Nishida T, Kubota S, Takigawa M, Kurabayashi M. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension. 2007;49:1120-1127.

    Not in our library10.1161/hypertensionaha.106.077537

25. 25.

    Lakatta EG, Sollott SJ. Perspectives on mammalian cardiovascular aging: humans to molecules. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2002;132:699-721.

    Not in our library10.1016/s1095-6433(02)00124-1

26. 26.

    Li G, Luna C, Qiu J, Epstein DL, Gonzalez P. Alterations in microRNA expression in stress-induced cellular senescence. Mech. Ageing Dev. 2009;130:731-741.

    Not in our library10.1016/j.mad.2009.09.002

27. 27.

    Maes OC, An J, Sarojini H, Wu H, Wang E. Changes in MicroRNA expression patterns in human fibroblasts after low-LET radiation. J. Cell. Biochem. 2008;105:824-834.

    Not in our library10.1002/jcb.21878

28. 28.

    Moura R, Tjwa M, Vandervoort P, Van Kerckhoven S, Holvoet P, Hoylaerts MF. Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE-/- mice. Circ. Res. 2008;103:1181-1189.

    Not in our library10.1161/circresaha.108.185645

29. 29.

    Mudhasani R, Zhu Z, Hutvagner G, Eischen CM, Lyle S, Hall LL, Lawrence JB, Imbalzano AN, Jones SN. Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells. J. Cell Biol. 2008;181:1055-1063.

    Not in our library10.1083/jcb.200802105

30. 30.
    microRNA Expression Patterns Reveal Differential Expression of Target Genes with Age · 2010

    No notice
31. 31.

    Nuovo GJ. In situ detection of microRNAs in paraffin embedded, formalin fixed tissues and the co-localization of their putative targets. Methods. 2010;52:307-315.

    Not in our library10.1016/j.ymeth.2010.08.009

32. 32.

    Ohgawara T, Kubota S, Kawaki H, Kondo S, Eguchi T, Kurio N, Aoyama E, Sasaki A, Takigawa M. Regulation of chondrocytic phenotype by micro RNA 18a: involvement of Ccn2/Ctgf as a major target gene. FEBS Lett. 2009;583:1006-1010.

    Not in our library10.1016/j.febslet.2009.02.025

33. 33.

    Ohnishi H, Oka T, Kusachi S, Nakanishi T, Takeda K, Nakahama M, Doi M, Murakami T, Ninomiya Y, Takigawa M, Tsuji T. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J. Mol. Cell. Cardiol. 1998;30:2411-2422.

    Not in our library10.1006/jmcc.1998.0799

34. 34.

    Panek AN, Posch MG, Alenina N, Ghadge SK, Erdmann B, Popova E, Perrot A, Geier C, Dietz R, Morano I, Bader M, Ozcelik C. Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS ONE. 2009;4:e6743.

    Not in our library10.1371/journal.pone.0006743

35. 35.

    Park SK, Prolla TA. Gene expression profiling studies of aging in cardiac and skeletal muscles. Cardiovasc. Res. 2005;66:205-212.

    Not in our library10.1016/j.cardiores.2005.01.005

36. 36.

    Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbely A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 2007;28:2539-2550.

    Not in our library10.1093/eurheartj/ehm037

37. 37.

    van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl Acad. Sci. USA. 2006;103:18255-18260.

    Not in our library10.1073/pnas.0608791103

38. 38.

    van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science. 2007;316:575-579.

    Not in our library10.1126/science.1139089

39. 39.

    Shan SW, Lee DY, Deng Z, Shatseva T, Jeyapalan Z, Du WW, Zhang Y, Xuan JW, Yee SP, Siragam V, Yang BB. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat. Cell Biol. 2009;11:1031-1038.

    Not in our library10.1038/ncb1917

40. 40.

    Shi-Wen X, Leask A, Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 2008;19:133-144.

    Not in our library10.1016/j.cytogfr.2008.01.002

Cited by papers we hold 6

• Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players · 2021
  No notice
• Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications · 2016
  No notice
• Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling · 2016
  No notice
• Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy · 2015
  No notice
• MicroRNAs in age‐related diseases · 2013
  No notice
• MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart · 2012
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.